|4May 31, 5:10 PM ET

Derovan Netanel 4

4 · ORAMED PHARMACEUTICALS INC. · Filed May 31, 2023

Insider Transaction Report

Form 4
Period: 2023-05-26
Derovan Netanel
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2023-05-26+20,500149,500 total
Footnotes (1)
  • [F1]Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION